Kyongbo’s antibiotics plant receives GMP certification from French regulator
Samsung Bioepis kicks off clinical studies on acute pancreatitis treatment
Healing dry-eye syndrome with optic nerve regeneration
Will gov’t support boost bio industry growth?
Samsung asks gov’t to cut red tape in biopharma industry
Celltrion set to begin clinical studies on Humira biosimilar
Bukwang Pharma to complete phase 2 studies on diabetes therapy by year-end
Nature Cell shares jump 14% despite CEO’s indictment for stock manipulation
Korea bans sale of 59 drugs used to treat high BP
Daewoong’s Nabota likely to gain FDA approval in Feb.